The diagnosis and management of chronic cough can be challenging. Only an estimated 50% of patients with chronic cough are accurately diagnosed. Recent advances in the understanding and management of refractory chronic cough have led to the development of novel therapies and ongoing clinical studies. In this second component of a two-part educational curriculum, pulmonary experts will discuss the prevalence, unmet clinical needs, and impact of chronic cough in patients who do not find relief from recommended management strategies. They will also apply the current diagnostic and management guidelines to 2 patient cases with refractory chronic cough, and finally they will review the clinical trial data and mechanisms of action of emerging therapies for patients with refractory chronic cough.
This activity is designed to meet the educational needs of pulmonary providers who participate in the care of patients with chronic cough including general pulmonologists, interventional pulmonologists, physicians-in-training, nurse practitioners including nurse navigators, and healthcare providers who provide care for these patients with chronic cough.
Upon completion of the educational activity, participants should be able to:
- Discuss the prevalence, unmet clinical needs, and impact of chronic cough in patients who do not find relief from recommended management strategies.
- Analyze the clinical trial data and mechanisms of action of emerging therapies for patients with refractory chronic cough.
- Summarize the current guidelines and emerging treatment strategies for the management of patients with chronic cough.
CME Credit provided by The American Thoracic Society
CME Accreditation Statement and Credit Designation
The American Thoracic Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Thoracic Society designates this internet live activity for a maximum of 1 AMA PRA Category 1 Credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030083. This activity is approved for 1 contact hour(s) (which includes 0 hour(s) of pharmacology).
Supported by an educational grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
Criteria for Success
Certificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at firstname.lastname@example.org.
About Our Faculty
Associate Professor of Medicine
Robert Larner, M.D., College of Medicine
University of Vermont
Garth Garrison is an Associate Professor in the Division of Pulmonary and Critical Care Medicine at the Robert Larner, M.D., College of Medicine and the University of Vermont Medical Center in Burlington, Vermont. He is a practicing Pulmonary and Critical Care physician as well as a medical educator currently serving as the program director for the UVM Pulmonary and Critical Care fellowship.
It is the policy of AKH and ATS to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH and ATS prior to accreditation of the activity. AKH and ATS planners and reviewers have no relevant financial relationships to disclose.
Garth W. Garrison, MD: has no financial relationships to disclose.
AKH Staff and Planners
Lynne Kolton Schneider, PhD, Medical Writer/Interviewer: has no financial relationships to disclose.
Dorothy Caputo, MA, BSN, RN, AKH Director of Accreditation, Planner: has no financial relationships to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C, Nurse Planner/Reviewer: has no financial relationships to disclose.
Patricia Brignoni, AKH Director of Operations: has no financial relationships to disclose.
Steve Eckert, AKH President & CEO, Planner: has no financial relationships to disclose.
Suzette Machado, MPA, CHCP, Associate Director of Education Programs and Accreditation; has no financial relationships to disclose
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. ATS and AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Copyright 2021 ATS and AKH Inc. No part of this publication may be produced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical photocopying, recording, or otherwise, without the prior permission of the publisher.